Prohibits cost sharing for insulin; provides that an insured shall not be subject to a deductible, copayment, coinsurance or any other cost sharing requirement for the purchase of insulin.
STATE OF NEW YORK
________________________________________________________________________
504--A
Cal. No. 91
2023-2024 Regular Sessions
IN SENATE
January 4, 2023
___________
Introduced by Sens. RIVERA, ADDABBO, COONEY, LIU, MARTINEZ -- read twice
and ordered printed, and when printed to be committed to the Committee
on Insurance -- recommitted to the Committee on Insurance in accord-
ance with Senate Rule 6, sec. 8 -- reported favorably from said
committee, ordered to first and second report, ordered to a third
reading, amended and ordered reprinted, retaining its place in the
order of third reading
AN ACT to amend the insurance law, in relation to prohibiting cost shar-
ing for insulin
The People of the State of New York, represented in Senate and Assem-bly, do enact as follows:
1 Section 1. Subparagraph (B) of paragraph 15-a of subsection (i) of
2 section 3216 of the insurance law, as amended by section 1 of part DDD
3 of chapter 56 of the laws of 2020, is amended to read as follows:
4 (B) Such coverage may be subject to annual deductibles and coinsurance
5 as may be deemed appropriate by the superintendent and as are consistent
6 with those established for other benefits within a given policy;
7 provided however, [the total amount] that [a covered person is required
8 to pay out of pocket for] covered prescription insulin drugs shall [be
9 capped at an amount not to exceed one hundred dollars per thirty-day
10 supply, regardless of the amount or type of insulin needed to fill such
11 covered person's prescription and regardless of the insured's] not be
12 subject to a deductible, copayment, coinsurance or any other cost shar-
13 ing requirement.
14 § 2. Subparagraph (B) of paragraph 7 of subsection (k) of section 3221
15 of the insurance law, as amended by section 2 of part DDD of chapter 56
16 of the laws of 2020, is amended to read as follows:
17 (B) Such coverage may be subject to annual deductibles and coinsurance
18 as may be deemed appropriate by the superintendent and as are consistent
19 with those established for other benefits within a given policy;
20 provided however, [the total amount] that [a covered person is required
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[] is old law to be omitted.
LBD02649-04-4
S. 504--A 2
1 to pay out of pocket for] covered prescription insulin drugs shall [be
2 capped at an amount not to exceed one hundred dollars per thirty-day
3 supply, regardless of the amount or type of insulin needed to fill such
4 covered person's prescription and regardless of the insured's] not be
5 subject to a deductible, copayment, coinsurance or any other cost shar-
6 ing requirement.
7 § 3. Paragraph 2 of subsection (u) of section 4303 of the insurance
8 law, as amended by section 3 of part DDD of chapter 56 of the laws of
9 2020, is amended to read as follows:
10 (2) Such coverage may be subject to annual deductibles and coinsurance
11 as may be deemed appropriate by the superintendent and as are consistent
12 with those established for other benefits within a given policy;
13 provided however, [the total amount] that [a covered person is required
14 to pay out of pocket for] covered prescription insulin drugs shall [be
15 capped at an amount not to exceed one hundred dollars per thirty-day
16 supply, regardless of the amount or type of insulin needed to fill such
17 covered person's prescription and regardless of the insured's] not be
18 subject to a deductible, copayment, coinsurance or any other cost shar-
19 ing requirement.
20 § 4. This act shall take effect January 1, 2025 and shall apply to any
21 policy or contract issued, renewed, modified, altered, or amended on or
22 after such date.
